doi	title	authors	title_name	year	downloads	visitors	countries
10.4155/fmc.14.151	Research progress of indoleamine 2,3-dioxygenase inhibitors	Tianze Jiang, Yingying Sun, Zhichao Yin, Sen Feng, Liping Sun, Zhiyu Li	Future Medicinal Chemistry	2015	106	72	16
10.2217/imt.15.35	Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma	Douglas B Johnson, Igor Puzanov, Mark C Kelley	Immunotherapy	2015	50	46	14
10.2217/fmb.14.103	 Leishmania and the macrophage: a multifaceted interaction 	Maria Podinovskaia, Albert Descoteaux	Future Microbiology	2015	50	40	14
10.2217/fmb.14.121	 Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda 	Francesco G De Rosa, Silvia Corcione, Rossana Cavallo, Giovanni Di Perri, Matteo Bassetti	Future Microbiology	2015	52	39	19
10.2217/epi.14.80	Genetic alterations of DNA methylation machinery in human diseases	Tewfik Hamidi, Anup Kumar Singh, Taiping Chen	Epigenomics	2015	36	35	17
10.2217/nnm.15.65	Graphene-based nanomaterials: biological and medical applications and toxicity	Fernanda MP Tonelli, Vânia AM Goulart, Katia N Gomes, Marina S Ladeira, Anderson K Santos, Eudes Lorençon, Luiz O Ladeira, Rodrigo R Resende	Nanomedicine	2015	38	35	14
10.2217/epi.14.85	An update on the epigenetics of psychotic diseases and autism	Hamid Mostafavi Abdolmaleky, Jin-Rong Zhou, Sam Thiagalingam	Epigenomics	2015	38	34	16
10.2217/epi.14.94	Targeted deep DNA methylation analysis of circulating cell-free DNA in plasma using massively parallel semiconductor sequencing	Felipe Vaca-Paniagua, Javier Oliver, Andre Nogueira da Costa, Philippe Merle, James McKay, Zdenko Herceg, Reetta Holmila	Epigenomics	2015	38	34	14
10.2217/nnm.13.212	pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances	Fenghua Meng, Yinan Zhong, Ru Cheng, Chao Deng, Zhiyuan Zhong	Nanomedicine	2014	45	33	12
10.2217/nnm.15.7	Biodegradable chitosan nanoparticles in drug delivery for infectious disease	Angelo Landriscina, Jamie Rosen, Adam J Friedman	Nanomedicine	2015	37	31	15
10.2217/nnm.14.154	Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells	Sangeetha Krishnamurthy, Xiyu Ke, Yi Yan Yang	Nanomedicine	2015	34	30	12
10.2217/nnm.14.169	Gold nanoparticles for photoacoustic imaging	Wanwan Li, Xiaoyuan Chen	Nanomedicine	2015	32	30	11
10.4155/fmc.15.13	Small-molecule MDM2-p53 inhibitors: recent advances	Bian Zhang, Bernard T Golding, Ian R Hardcastle	Future Medicinal Chemistry	2015	32	30	12
10.4155/tde.14.122	miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence	Mitsuhiko Osaki, Futoshi Okada, Takahiro Ochiya	Therapeutic delivery	2015	39	30	15
10.2217/fmb.14.66	Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance	Jessica MA Blair, Grace E Richmond, Laura JV Piddock	Future Microbiology	2014	32	29	17
10.2217/epi.14.84	Oxidative stress and DNA methylation regulation in the metabolic syndrome	Sabrina Yara, Jean-Claude Lavoie, Emile Levy	Epigenomics	2015	34	27	14
10.2217/fmb.14.48	Molecular pathogenesis of Klebsiella pneumoniae	Bei Li, Yuling Zhao, Changting Liu, Zhenhong Chen, Dongsheng Zhou	Future Microbiology	2014	33	27	17
10.2217/nnm.14.165	Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism	Gabriela da Rocha Lindner, Danúbia Bonfanti Santos, Dirleise Colle, Eduardo Luiz Gasnhar Moreira, Rui Daniel Prediger, Marcelo Farina, Najeh Maissar Khalil, Rubiana Mara Mainardes	Nanomedicine	2015	34	27	7
10.4155/fmc.15.93	Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies	Weimin Fan, Jinjia Chang, Peifeng Fu	Future Medicinal Chemistry	2015	31	27	9
10.2217/epi.14.91	Targeting BET bromodomains for cancer treatment	Marie Jung, Kathy A Gelato, Amaury Fernández-Montalván, Stephan Siegel, Bernard Haendler	Epigenomics	2015	33	26	11
10.2217/nnm.14.135	Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach	Joana M Silva, Gaëlle Vandermeulen, Vanessa G Oliveira, Sandra N Pinto, Catarina Rodrigues, Ana Salgado, Carlos A Afonso, Ana S Viana, Christine Jérôme, Liana C Silva, Luis Graca, Véronique Préat, Helena F Florindo	Nanomedicine	2014	57	26	8
10.2217/nnm.14.147	Gold nanoparticle-mediated photothermal therapy: current status and future perspective	Sekyu Hwang, Jutaek Nam, Sungwook Jung, Jaejung Song, Hyunmi Doh, Sungjee Kim	Nanomedicine	2014	30	26	12
10.2217/nnm.15.36	Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles	Kiran Chaturvedi, Kuntal Ganguly, Anandrao R Kulkarni, Walter E Rudzinski, Leslie Krauss, Mallikarjuna N Nadagouda, Tejraj M Aminabhavi	Nanomedicine	2015	34	26	11
10.4155/fmc.13.207	Reverse docking: a powerful tool for drug repositioning and drug rescue	Prashant S Kharkar, Sona Warrier, Ram S Gaud	Future Medicinal Chemistry	2014	33	26	10
10.4155/tde.15.28	A sight on protein-based nanoparticles as drug/gene delivery systems	Sara Salatin, Mitra Jelvehgari, Solmaz Maleki-Dizaj, Khosro Adibkia	Therapeutic delivery	2015	28	26	10
10.2217/nnm.12.205	Zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats	Rinku D Umrani, Kishore M Paknikar	Nanomedicine	2014	26	25	8
10.2217/nnm.15.58	Carbohydrate-based materials for targeted delivery of drugs and genes to the liver	Marya Ahmed, Ravin Narain	Nanomedicine	2015	30	25	11
10.2217/nnm.15.67	Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs	Rui Yin, Tanupriya Agrawal, Usman Khan, Gaurav K Gupta, Vikrant Rai, Ying-Ying Huang, Michael R Hamblin	Nanomedicine	2015	28	25	13
10.4155/fmc.14.149	Progress toward JAK1-selective inhibitors	Christel J Menet, Oscar Mammoliti, Miriam López-Ramos	Future Medicinal Chemistry	2015	34	25	7
10.4155/tde.14.91	PLGA: a unique polymer for drug delivery	Deepak N Kapoor, Amit Bhatia, Ripandeep Kaur, Ruchi Sharma, Gurvinder Kaur, Sanju Dhawan	Therapeutic delivery	2015	29	25	12
10.2217/imt.15.15	Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors	Hinrich Abken	Immunotherapy	2015	29	24	7
10.2217/nnm.15.82	Nanomaterials for wound healing: scope and advancement	Irina Kalashnikova, Soumen Das, Sudipta Seal	Nanomedicine	2015	23	23	10
10.4155/bio.13.296	Microfluidic paper-based devices for bioanalytical applications	Murilo Santhiago, Emilia W Nery, Glauco P Santos, Lauro T Kubota	Bioanalysis	2014	29	23	11
10.4155/fmc.15.49	Recent progress in natural products as DPP-4 inhibitors	Yuanyuan Gao, Yong Zhang, Jianming Zhu, Bo Li, Zhao Li, Weiliang Zhu, Jiye Shi, Qi Jia, Yiming Li	Future Medicinal Chemistry	2015	28	23	7
10.4155/fmc.15.88	Targeting autophagy to overcome drug resistance in cancer therapy	Ankit Kumar, Umesh Kumar Singh, Anurag Chaudhary	Future Medicinal Chemistry	2015	29	23	8
10.2217/epi.14.59	Epigenetic mechanisms of breast cancer: an update of the current knowledge	Seher Karsli-Ceppioglu, Aslihan Dagdemir, Gaëlle Judes, Marjolaine Ngollo, Frédérique Penault-Llorca, Amaury Pajon, Yves-Jean Bignon, Dominique Bernard-Gallon	Epigenomics	2014	27	22	11
10.2217/epi.14.71	Lifestyle, pregnancy and epigenetic effects	Subit Barua, Mohammed A Junaid	Epigenomics	2015	26	22	11
10.2217/nmt.13.75	When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia	Gregory S Day, David F Tang-Wai	Neurodegenerative disease management	2014	26	22	10
10.2217/nnm.14.206	Nanomedicine for the treatment of Alzheimer's disease	Maria Gregori, Massimo Masserini, Simona Mancini	Nanomedicine	2015	25	22	10
10.4155/fmc.15.34	Recent advances in research of natural and synthetic bioactive quinolines	Po-Yee Chung, Zhao-Xiang Bian, Ho-Yuen Pun, Dessy Chan, Albert Sun-Chi Chan, Chung-Hin Chui, Johnny Cheuk-On Tang, Kim-Hung Lam	Future Medicinal Chemistry	2015	27	22	13
10.2217/fon.15.23	EGFR mutations in lung cancer: from tissue testing to liquid biopsy	Francesca Fenizia, Antonella De Luca, Raffaella Pasquale, Alessandra Sacco, Laura Forgione, Matilde Lambiase, Alessia Iannaccone, Nicoletta Chicchinelli, Renato Franco, Antonio Rossi, Alessandro Morabito, Gaetano Rocco, Maria Carmela Piccirillo, Nicola Normanno	Future Oncology	2015	22	21	9
10.2217/nnm.14.185	Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis	Maria Jose Morilla, Eder Lilia Romero	Nanomedicine	2015	26	21	7
10.2217/nnm.14.219	Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics	James R Nicol, Dorian Dixon, Jonathan A Coulter	Nanomedicine	2015	24	21	12
10.2217/nnm.15.61	Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents	Jing Zhao, Si-Shen Feng	Nanomedicine	2015	23	21	11
10.2217/epi.14.75	Epigenetic regulation of chronic pain	Lingli Liang, Brianna Marie Lutz, Alex Bekker, Yuan-Xiang Tao	Epigenomics	2015	21	20	13
10.2217/fmb.15.8	Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria	Yves Briers, Rob Lavigne	Future Microbiology	2015	27	20	10
10.2217/fon.13.222	Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy	Nobuyoshi Kosaka, Yusuke Yoshioka, Naoomi Tominaga, Keitaro Hagiwara, Takeshi Katsuda, Takahiro Ochiya	Future Oncology	2014	24	20	8
10.4155/fmc.15.61	N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs	Siddappa A Patil, Shivaputra A Patil, Renukadevi Patil, Rangappa S Keri, Srinivasa Budagumpi, Geetha R Balakrishna, Matthias Tacke	Future Medicinal Chemistry	2015	29	20	14
10.2217/nnm.13.223	Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications	Hélder A Santos, Ermei Mäkilä, Anu J Airaksinen, Luis M Bimbo, Jouni Hirvonen	Nanomedicine	2014	23	19	13
10.2217/nnm.14.126	Gold nanoparticles for photothermally controlled drug release	Ariel R Guerrero, Natalia Hassan, Carlos A Escobar, Fernando Albericio, Marcelo J Kogan, Eyleen Araya	Nanomedicine	2014	22	19	12
10.2217/nnm.14.171	Gold nanoparticles as contrast agents in x-ray imaging and computed tomography	Lisa E Cole, Ryan D Ross, Jennifer MR Tilley, Tracy Vargo-Gogola, Ryan K Roeder	Nanomedicine	2015	21	19	14
10.2217/nnm.15.53	Silicon nanostructures for cancer diagnosis and therapy	Fei Peng, Zhaohui Cao, Xiaoyuan Ji, Binbin Chu, Yuanyuan Su, Yao He	Nanomedicine	2015	19	19	9
10.2217/epi.14.73	Epigenetic therapy for solid tumors: from bench science to clinical trials	Yen-Yi Juo, Xue-Jun Gong, Ankita Mishra, Xiao Cui, Stephen B Baylin, Nilofer S Azad, Nita Ahuja	Epigenomics	2015	18	18	10
10.2217/epi.14.76	Improved tagmentation-based whole-genome bisulfite sequencing for input DNA from less than 100 mammalian cells	Hanlin Lu, Zhimei Yuan, Tao Tan, Junwen Wang, Juyong Zhang, Hui-Juan Luo, Yudong Xia, Weizhi Ji, Fei Gao	Epigenomics	2015	26	18	5
10.2217/fmb.13.165	Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease	Denise Mafra, Julie C Lobo, Amanda F Barros, Laetitia Koppe, Nosratola D Vaziri, Denis Fouque	Future Microbiology	2014	18	18	9
10.2217/fmb.14.43	Immunity to visceral leishmaniasis: implications for immunotherapy	Forough Khadem, Jude E Uzonna	Future Microbiology	2014	19	18	5
10.2217/imt.14.123	CAR T-cell therapy: toxicity and the relevance of preclinical models	Milena Kalaitsidou, Gray Kueberuwa, Antje Schütt, David Edward Gilham	Immunotherapy	2015	23	18	8
10.2217/nnm.15.68	Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges	Mahfoozur Rahman, Sohail Akhter, Mohammad Zaki Ahmad, Javed Ahmad, Richard T Addo, Farhan Jalees Ahmad, Chantal Pichon	Nanomedicine	2015	25	18	5
10.2217/rme.14.35	Cell-based therapy approaches: the hope for incurable diseases	Ella Buzhor, Lucy Leshansky, Jacob Blumenthal, Hila Barash, David Warshawsky, Yaron Mazor, Ronit Shtrichman	Regenerative Medicine	2014	29	18	11
10.2217/rme.14.86	Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential	Tianci Chu, Hengxing Zhou, Lu Lu, Xiaohong Kong, Tianyi Wang, Bin Pan, Shiqing Feng	Regenerative Medicine	2015	19	18	10
10.4155/bio.14.119	Analytical protocols based on LC–MS, GC–MS and CE–MS for nontargeted metabolomics of biological tissues	Shama Naz, Délia Chaves Moreira dos Santos, Antonia García, Coral Barbas	Bioanalysis	2014	19	18	6
10.4155/bio.14.51	Recent developments in liquid-phase separation techniques for metabolomics	Rawi Ramautar, Gerhardus J de Jong	Bioanalysis	2014	18	18	6
10.4155/fmc.15.95	Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon	Zacharenia Nikitaki, Ioannis Michalopoulos, Alexandros G Georgakilas	Future Medicinal Chemistry	2015	19	18	9
10.4155/tde.15.47	Why most oral insulin formulations do not reach clinical trials	Marlene Lopes, Susana Simões, Francisco Veiga, Raquel Seiça, António Ribeiro	Therapeutic delivery	2015	18	18	8
10.2217/epi.14.43	Strategies for validation and testing of DNA methylation biomarkers	Christa Noehammer, Walter Pulverer, Melanie R Hassler, Manuela Hofner, Matthias Wielscher, Klemens Vierlinger, Triantafillos Liloglou, David McCarthy, Taylor J Jensen, Anders Nygren, Henning Gohlke, Geert Trooskens, Maarten Braspenning, Wim Van Criekinge, Gerda Egger, Andreas Weinhaeusel	Epigenomics	2014	18	17	8
10.2217/epi.15.32	The NSD family of protein methyltransferases in human cancer	Theodore Vougiouklakis, Ryuji Hamamoto, Yusuke Nakamura, Vassiliki Saloura	Epigenomics	2015	18	17	8
10.2217/fmb.14.88	 Regulation of biofilm formation in Salmonella enterica serovar Typhimurium 	Roger Simm, Irfan Ahmad, Mikael Rhen, Soazig Le Guyon, Ute Römling	Future Microbiology	2014	21	17	10
10.2217/imt.15.49	Programmed death-1 & its ligands: promising targets for cancer immunotherapy	Rajeev K Shrimali, John E Janik, Rasha Abu-Eid, Mikayel Mkrtichyan, Samir N Khleif	Immunotherapy	2015	22	17	4
10.2217/nnm.14.195	Graphene in neurosurgery: the beginning of a new era	Maria Caffo, Lucia Merlo, Daniele Marino, Gerardo Caruso	Nanomedicine	2015	20	17	9
10.2217/nnm.14.225	Regulation of stem cell fate by nanomaterial substrates	Omid Mashinchian, Lesley-Anne Turner, Matthew J Dalby, Sophie Laurent, Mohammad Ali Shokrgozar, Shahin Bonakdar, Mohammad Imani, Morteza Mahmoudi	Nanomedicine	2015	22	17	9
10.2217/nnm.14.36	3D nano/microfabrication techniques and nanobiomaterials for neural tissue regeneration	Wei Zhu, Christopher O'Brien, Joseph R O'Brien, Lijie Grace Zhang	Nanomedicine	2014	20	17	12
10.2217/nnm.15.29	PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting	Yuliana Monsalve, Giovanni Tosi, Barbara Ruozi, Daniela Belletti, Antonietta Vilella, Michele Zoli, Maria Angela Vandelli, Flavio Forni, Betty L López, Ligia Sierra	Nanomedicine	2015	20	17	12
10.2217/whe.14.73	Polycystic ovary syndrome and insulin: our understanding in the past, present and future	Stéphanie B Mayer, William S Evans, John E Nestler	Women's health (London, England)	2015	21	17	9
10.4155/bio.14.145	Quantitation of human peptides and proteins via MS: review of analytically validated assays	Derek L Chappell, Michael E Lassman, Thomas McAvoy, Mingxiang Lin, Daniel S Spellman, Omar F Laterza	Bioanalysis	2014	20	17	7
10.4155/bio.14.272	Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis	Venkata Kolli, Katherine N Schumacher, Eric D Dodds	Bioanalysis	2015	24	17	4
10.4155/fmc.14.166	Nucleoside analogs and tuberculosis: new weapons against an old enemy	Valentina Ferrari, Michaela Serpi	Future Medicinal Chemistry	2015	19	17	7
10.4155/tde.14.106	Formulation design for topical drug and nanoparticle treatment of skin disease	Anthony P Raphael, Gabriela Garrastazu, Fabio Sonvico, Tarl W Prow	Therapeutic delivery	2015	20	17	10
10.2217/epi.15.36	Transgenerational epigenetic inheritance: adaptation through the germline epigenome?	Lexie Prokopuk, Patrick S Western, Jessica M Stringer	Epigenomics	2015	20	16	9
10.2217/fmb.14.63	Current molecular methods in epidemiological typing of Acinetobacter baumannii	Rayane Rafei, Marie Kempf, Matthieu Eveillard, Fouad Dabboussi, Monzer Hamze, Marie-Laure Joly-Guillou	Future Microbiology	2014	18	16	12
10.2217/imt.14.16	Radioimmunotherapy with α-particle-emitting radionuclides	Christof Seidl	Immunotherapy	2014	20	16	5
10.2217/nmt.14.34	Frontotemporal dementia: diagnosis, deficits and management	Nicholas T Bott, Anneliese Radke, Melanie L Stephens, Joel H Kramer	Neurodegenerative disease management	2014	19	16	10
10.2217/nnm.14.196	Dendrimer–nanoparticle conjugates in nanomedicine	Audrey Parat, Catalina Bordeianu, Hanna Dib, Antonio Garofalo, Aurélie Walter, Sylvie Bégin-Colin, Delphine Felder-Flesch	Nanomedicine	2015	21	16	9
10.2217/nnm.14.41	A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications	Jaya Raju Lakkakula, Rui Werner Maçedo Krause	Nanomedicine	2014	17	16	15
10.2217/nnm.14.69	Crucial role of the protein corona for the specific targeting of nanoparticles	Morteza Mahmoudi, Sara Sheibani, Abbas S Milani, Farhad Rezaee, Maxime Gauberti, Rassoul Dinarvand, Hojatollah Vali	Nanomedicine	2015	24	16	7
10.2217/nnm.15.112	Green synthesis of therapeutic nanoparticles: an expanding horizon	Sandeep Kumar, Viney Lather, Deepti Pandita	Nanomedicine	2015	17	16	8
10.4155/bio.14.296	Quantitation of protein post-translational modifications using isobaric tandem mass tags	Hui-Chung Liang, Emma Lahert, Ian Pike, Malcolm Ward	Bioanalysis	2015	19	16	7
10.4155/fmc.14.140	Molecularly imprinted polymeric micro- and nano-particles for the targeted delivery of active molecules	Mariacristina Gagliardi, Barbara Mazzolai	Future Medicinal Chemistry	2015	17	16	3
10.4155/fmc.14.71	Synthesis of medicinally relevant terpenes: reducing the cost and time of drug discovery	Daniel J Jansen, Ryan A Shenvi	Future Medicinal Chemistry	2014	25	16	6
10.4155/fmc.15.36	P-glycoprotein and membrane roles in multidrug resistance	Ricardo J Ferreira, Daniel JVA dos Santos, Maria-José U Ferreira	Future Medicinal Chemistry	2015	19	16	8
10.4155/fmc.15.71	Carbonic anhydrase IX inhibitors in cancer therapy: an update	Claudiu T Supuran, Jean-Yves Winum	Future Medicinal Chemistry	2015	19	16	11
10.4155/tde.14.125	Polymersome-based drug-delivery strategies for cancer therapeutics	Tayebeh Anajafi, Sanku Mallik	Therapeutic delivery	2015	19	16	8
10.2217/cns.14.51	Brain metastases: an overview	F Bertolini, A Spallanzani, A Fontana, R Depenni, G Luppi	CNS oncology	2015	15	15	9
10.2217/epi.14.61	Polycomb group protein-mediated histone modifications during cell differentiation	Abdul Aziz Khan, Andrew Jeoungun Lee, Tae-Young Roh	Epigenomics	2015	16	15	12
10.2217/epi.15.10	Role of epigenetic modifications in luminal breast cancer	Hany A Abdel-Hafiz, Kathryn B Horwitz	Epigenomics	2015	19	15	9
10.2217/fca.14.77	Vascular injury and repair: a potential target for cell therapies	Andrew Mitchell, Takeshi Fujisawa, David Newby, Nicholas Mills, Nicholas L Cruden	Future Cardiology	2015	18	15	7
10.2217/fon.13.274	3D tumor models: history, advances and future perspectives	Parul Benien, Archana Swami	Future Oncology	2014	17	15	9
10.2217/nnm.13.191	Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles	Randall Toy, Pubudu M Peiris, Ketan B Ghaghada, Efstathios Karathanasis	Nanomedicine	2014	15	15	9
10.2217/nnm.13.192	Lipid-based nanoparticles in the systemic delivery of siRNA	Qiaoya Lin, Juan Chen, Zhihong Zhang, Gang Zheng	Nanomedicine	2014	15	15	9
10.2217/nnm.13.198	X-ray-induced nanoparticle-based photodynamic therapy of cancer	Xiaoju Zou, Mingzhen Yao, Lun Ma, Marius Hossu, Xiumei Han, Petras Juzenas, Wei Chen	Nanomedicine	2014	20	15	6
10.2217/nnm.14.167	Advances in studies of nanoparticle–biomembrane interactions	Xiao Cong He, Min Lin, Fei Li, Bao Yong Sha, Feng Xu, Zhi Guo Qu, Lin Wang	Nanomedicine	2015	15	15	7
